Stay connected with VYEPTI

Sign up to learn more about migraine prevention, gain access to resources and tips, and see how VYEPTI may help.

Email registration icon

*Required field

Have you been prescribed VYEPTI?*

Enroll in VYEPTI GO

VYEPTI GO logo

VYEPTI GO is a personalized support program that offers helpful information and resources. Registered nurses are available Monday through Saturday to answer questions and provide information on topics such as migraine, the infusion process, the benefits of treatment with VYEPTI, and can offer 1-on 1 support and encouragement throughout your treatment journey. They can also offer informational emails, text messages, and appointment reminders.

SMS TERMS AND CONDITIONS

By agreeing to these VYEPTI GO Support Program (“Program”) text message terms and conditions, you agree to receive text messages on your mobile device subject to the Terms & Conditions described below. You also consent to receive autodialed and/or pre-recorded calls and/or text messages from or on behalf of VYEPTI at the telephone number provided above. You understand that this consent is not a condition of purchase or use of VYEPTI or of any Lundbeck product or service.

  • Message frequency will vary by use while enrolled in the Program
  • There is no fee payable to Lundbeck to receive text messages; however, your carrier’s message and data rates may apply
  • Data obtained from you in connection with your registration for, and use of, this SMS service may include your phone number and/or email address, related carrier information and will be used to administer this Program and to provide Program benefits such as information about your prescription, appointment reminders, as well as Program updates and alerts
  • Lundbeck will not be liable for any delays in the receipt of any SMS messages, as delivery is subject to effective transmission from your network operator
  • This Program is valid with most major US carriers, including: Verizon Wireless, Sprint, Nextel, Boost, T-Mobile®, AT&T, ACS Wireless, Bluegrass Cellular, Alltel, C Spire Wireless, Carolina West Wireless, Cellcom, Cellular One of East Central Illinois (ECIT), Cincinnati Bell, Cricket, Duet IP (AKA Max/Benton/Albany), Element Mobile, Epic Touch, GCI, Golden State Cellular, Hawkeye (Chat Mobility), Hawkeye (NW Missouri Cellular), Illinois Valley Cellular, Inland Cellular, iWireless, Keystone Wireless (Immix/PC Management), MetroPCS, Mobi PCS, Mosaic Telecom, MTPCS Cellular One (Cellone Nation), Nex-Tech Wireless, nTelos, Panhandle Telecommunication Systems, Pioneer Telephone, Plateau, Revol Wireless, Rina-All West, Rina-Cambridge Telecom Coop, Rina-Custer, Rina-Eagle Valley Comm, Rina-Farmers Mutual Telephone Co, Rina Manti, Rina-Nucla Nutria Telephone Co, Rina-Silver Star, Rina-South Central Comm, Rina-Syringa, Rina-UBET, Simmetry Wireless, South Canaan/Cellular One of NEPA, Thumb Cellular, Union Wireless, United Wireless, U.S. Cellular, Viaero Wireless, Virgin Mobile, West Central Wireless (includes Five Star Wireless)
  • Lundbeck may be required to contact the user if an adverse event is reported
  • Lundbeck reserves the right to rescind, revoke, or amend the VYEPTI GO Support Program without notice at any time
  • You can unsubscribe from the Program by texting STOP to 35865. For questions about this Program, text HELP or contact the customer support center at 833-4-VYEPTI
  • Carriers are not liable for delayed or undelivered messages
  • Please review our Privacy Policy here
IMPORTANT SAFETY INFORMATION
AND APPROVED USE

Do not receive VYEPTI if you have a known allergy to eptinezumab-jjmr or its ingredients.

APPROVED USE

VYEPTI is a prescription medicine used for the preventive treatment of migraine in adults.

VYEPTI may cause allergic reactions. Call your healthcare provider or get emergency medical help right away if you have any symptoms of an allergic reaction: rash; swelling of your face, lips, tongue, or throat; if you have trouble breathing; hives; or redness in your face.

Before starting VYEPTI, tell your healthcare provider about all your medical conditions, including if you are pregnant or plan to become pregnant, or you are breastfeeding or plan to breastfeed.

Tell your healthcare provider about all the medicines you take, including any prescription and over-the-counter medicines, vitamins, or herbal supplements.

The most common side effects of VYEPTI include stuffy nose and scratchy throat, and allergic reactions.

These are not all the possible side effects of VYEPTI. Tell your healthcare provider if you have any side effect that bothers you or that does not go away.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

For more information, please see the Prescribing Information and Patient Information.

APPROVED USE

VYEPTI is a prescription medicine used for the preventive treatment of migraine in adults.

IMPORTANT SAFETY INFORMATION
AND APPROVED USE

Do not receive VYEPTI if you have a known allergy to eptinezumab-jjmr or its ingredients.

VYEPTI may cause allergic reactions. Call your healthcare provider or get emergency medical help right away if you have any symptoms of an allergic reaction: rash; swelling of your face, lips, tongue, or throat; if you have trouble breathing; hives; or redness in your face.

Before starting VYEPTI, tell your healthcare provider about all your medical conditions, including if you are pregnant or plan to become pregnant, or you are breastfeeding or plan to breastfeed.

Tell your healthcare provider about all the medicines you take, including any prescription and over-the-counter medicines, vitamins, or herbal supplements.

The most common side effects of VYEPTI include stuffy nose and scratchy throat, and allergic reactions.

These are not all the possible side effects of VYEPTI. Tell your healthcare provider if you have any side effect that bothers you or that does not go away.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

For more information, please see the Prescribing Information and Patient Information.